The Latest Pain Relief Industry Statistics Explained
The global pain management devices market size was estimated at USD 5.93 billion in 2018
The statistic that the global pain management devices market size was estimated at USD 5.93 billion in 2018 indicates the total value of sales related to medical devices specifically designed to help manage and alleviate pain worldwide during that year. This figure reflects the significant demand for pain management solutions and highlights the substantial market potential for companies operating in this sector. The market size suggests the economic importance and growth opportunities within the pain management industry, emphasizing the increasing focus on developing and utilizing innovative technologies to address the prevalent issue of pain management across various medical conditions and patient populations.
The pain management devices market is expected to reach USD 8.22 billion by 2025
This statistic indicates that the pain management devices market is projected to grow significantly, reaching a value of USD 8.22 billion by the year 2025. This forecast suggests a substantial increase in the demand for pain management devices, driven by factors such as the rising prevalence of chronic pain conditions, advancements in technology for pain relief, and an aging population requiring more pain management solutions. The expanding market indicates a growing opportunity for companies operating in the pain management device industry to meet the needs of healthcare providers and patients seeking effective and innovative solutions for managing pain.
The North America region constituted the largest market share of over 50% in 2018 in the pain relief industry
The statistic indicates that in 2018, the North America region held the largest market share in the pain relief industry, accounting for over 50% of total sales. This suggests that North America was the dominant market for pain relief products during that year, with a significant portion of industry revenue generated from this region. Factors such as the population size, healthcare infrastructure, consumer preferences, and marketing strategies may have contributed to North America’s strong position in the pain relief industry. This statistic highlights the importance of the North American market for companies operating in the pain relief sector and underscores the potential opportunities and challenges associated with this region.
As of 2018, neurostimulation devices accounted for the largest market share of over 37%
This statistic indicates that in 2018, neurostimulation devices held the highest market share among various medical devices, comprising more than 37% of the market. Neurostimulation devices are medical instruments that use electrical impulses to modulate and regulate the nervous system, often being utilized as a treatment for chronic pain, neurological disorders, and other medical conditions. The fact that neurostimulation devices accounted for such a significant market share indicates their growing importance and adoption within the medical industry. This trend could be attributed to advancements in technology, increased awareness of neurostimulation therapies, and the need for non-invasive and effective treatment options for various health conditions.
Approximately 2.32 billion people globally suffer from pain
The statistic that approximately 2.32 billion people globally suffer from pain highlights the widespread prevalence of pain as a health issue affecting individuals around the world. Pain can stem from a variety of causes, including diseases, injuries, and chronic conditions, and can significantly impact an individual’s quality of life and overall well-being. This statistic underscores the importance of addressing pain management and healthcare systems that can provide effective treatments and support for those experiencing pain. It also emphasizes the need for further research, awareness, and resources dedicated to pain management to alleviate the suffering experienced by such a large proportion of the global population.
Chronic low back pain is experienced by about 23% of the world’s population
The statistic that about 23% of the world’s population experiences chronic low back pain highlights the significant and widespread prevalence of this health issue globally. Chronic low back pain can have a substantial impact on individuals’ quality of life, leading to reduced mobility, work productivity, and psychological well-being. The statistic indicates that a substantial portion of the global population is affected by this condition, emphasizing the importance of addressing and managing chronic low back pain through effective prevention and treatment strategies. Additionally, this statistic underscores the need for further research and public health initiatives to alleviate the burden of chronic low back pain on individuals and societies worldwide.
The global pain relief therapy market size is valued at USD 55,275 million in 2017
The statistic states that the global market for pain relief therapy was valued at USD 55,275 million in the year 2017. This means that the total revenue generated by products and services related to pain relief therapy, such as medications, devices, and treatments, amounted to over 55 billion US dollars. This indicates a substantial market for addressing pain management and highlights the significant demand for solutions to alleviate pain and improve quality of life globally. The figure serves as a key indicator of the size and economic importance of the pain relief therapy market in 2017.
The global pain relief therapy market is projected to reach USD 71,431 million by 2025
This statistic indicates that the global pain relief therapy market is anticipated to grow significantly, with a projected value of USD 71,431 million by the year 2025. This suggests a substantial increase in the demand for pain relief products and services worldwide, likely driven by factors such as an aging population, rising prevalence of chronic pain conditions, and advancements in pain management technologies. The projected market value signifies a lucrative opportunity for businesses operating in the pain relief therapy sector, as well as a growing need for effective and efficient pain management solutions to meet the escalating demand from consumers.
The pharmaceutical laxatives segment generated the maximum revenue, contributing nearly one-fifth of the total market share in 2017
In 2017, the pharmaceutical laxatives segment within the market generated the highest revenue compared to other segments, accounting for approximately one-fifth of the total market share. This indicates that pharmaceutical laxatives were a significant contributor to the overall market performance, suggesting a substantial demand for these products among consumers. The high revenue generated by this segment emphasizes the importance and popularity of pharmaceutical laxatives in meeting the needs of individuals seeking relief from constipation and other related gastrointestinal issues. This statistic serves as a key indicator of the market importance and consumer preferences within the pharmaceutical laxatives industry in 2017.
The analgesics market was valued at approximately USD 26.4 billion in 2017
The statistic “The analgesics market was valued at approximately USD 26.4 billion in 2017” represents the total monetary worth of the market for pain-relief medications in the given year. This value includes all sales of analgesic products such as over-the-counter painkillers, prescription medications, and topical creams. The USD 26.4 billion figure indicates the significant demand for pain relief remedies in 2017, reflecting the prevalence of pain-related conditions and the widespread use of analgesics by consumers globally. This statistic serves as a key indicator of market size and potential growth opportunities in the pharmaceutical industry focused on pain management.
The global analgesics market is expected to register a CAGR of 4% during the forecast period of 2018 to 2025
This statistic indicates that the global analgesics market is projected to experience a Compound Annual Growth Rate (CAGR) of 4% between the years 2018 and 2025. This percentage represents the annual growth rate at which the market is anticipated to expand over the specified forecast period. A CAGR of 4% suggests a moderate but steady growth trajectory for the analgesics market, implying an increasing demand for pain relief medication worldwide. Factors such as rising prevalence of chronic diseases, increasing aging population, and improving healthcare infrastructure may contribute to this growth in the market.
North America is expected to hold the largest share in the global analgesics market
The statistic “North America is expected to hold the largest share in the global analgesics market” indicates that North America, comprising the United States and Canada primarily, is projected to have the highest market share in the global analgesics market compared to other regions such as Europe, Asia-Pacific, and Latin America. This suggests that North America is likely to have the highest consumption, production, and revenue generation in the analgesics industry, which includes pain relief medications like aspirin, ibuprofen, and acetaminophen. Factors contributing to this dominance may include a large population, high healthcare expenditure, accessibility to healthcare facilities, and a higher prevalence of conditions requiring analgesic treatment in the region. The statistic highlights the significance of North America in the global market landscape for pain relief medications.
Opioids are the most commonly used type of medication for pain relief
This statistic indicates that among various types of medications available for pain relief, opioids are the most frequently utilized. Opioids are a class of medications primarily prescribed to manage moderate to severe pain symptoms. This trend could be driven by a variety of factors, including the efficacy of opioids in providing pain relief, the widespread availability of these medications, and the persistent need for effective pain management strategies. However, it’s important to recognize that the use of opioids for pain relief can also carry risks, such as the potential for tolerance, dependence, and addiction. Thus, while opioids remain a common choice for pain relief, healthcare providers and patients should carefully consider the benefits and risks associated with their use and explore alternative pain management strategies when appropriate.
Approximately 10 million Americans use opioids for long-term pain management
The statistic that approximately 10 million Americans use opioids for long-term pain management highlights a significant portion of the population relying on these medications for pain relief over an extended period. Opioids are commonly prescribed for chronic pain conditions, such as back pain or arthritis, but their long-term use raises concerns about addiction and potential adverse effects. This statistic underscores the widespread use of opioids in the United States to manage pain, shedding light on the complex challenges associated with balancing the benefits of pain relief with the risks of opioid dependence and misuse. Healthcare providers and policymakers need to carefully consider the appropriate use of opioids in long-term pain management to address the public health implications of this widespread practice.
The dental pain market is projected to reach a value of US$ 7,000 million by the end of 2028
The statistic indicates that the overall market size for products and services related to dental pain is estimated to increase to US$ 7,000 million by the end of 2028. This projection suggests a growing demand for solutions to alleviate dental pain among consumers. Factors such as increasing prevalence of dental issues, advancements in dental care technologies, and rising awareness about oral health could contribute to this market expansion. As a result, companies operating in the dental pain market may see opportunities for growth and innovation as they cater to the needs of individuals seeking relief from dental discomfort.
The topical products for pain relief is expected to grow at a 7.4% CAGR by 2025
The statistic indicates that the market for topical products designed for pain relief is projected to experience a Compound Annual Growth Rate (CAGR) of 7.4% by the year 2025. This implies a steady and consistent increase in the demand and sales of these pain relief products over the specified period. The growth rate suggests a positive outlook for the industry, with consumers likely turning to topical solutions for managing pain over traditional methods. Factors such as an aging population, increasing awareness and preference for non-invasive pain management options, and advancements in product formulation and effectiveness may contribute to the expected growth in this market segment.
The global over-the-counter pain medication market expected to reach USD 24.7 billion by 2027
The statistic indicates that the global market for over-the-counter pain medication is projected to grow to USD 24.7 billion by the year 2027. This represents a substantial increase in market value from its current size and suggests a high demand for pain relief products that do not require a prescription. Factors such as an aging population, increasing prevalence of chronic pain conditions, and growing awareness and usage of self-medication are likely contributing to this anticipated growth. Pharmaceutical companies and healthcare providers may need to adapt their strategies and offerings to meet the rising consumer need for accessible and effective pain relief options in the coming years.
Non-opioids are anticipated to witness a CAGR of 3.9% during 2018 to 2025.
This statistic indicates that non-opioids, which are medications that do not contain opioids, are expected to experience a Compound Annual Growth Rate (CAGR) of 3.9% over the period from 2018 to 2025. The CAGR is a measure used to determine the average annual growth rate of an investment over a specified period of time. In this context, the 3.9% CAGR suggests that the market for non-opioid medications is projected to grow steadily at that rate each year until 2025. This growth rate could be attributed to factors such as increasing awareness of the risks associated with opioid use and a shift towards alternative pain management strategies, driving the demand for non-opioid medications.
Globally, neuropathic pain affects around 7-10% of the general population
The statistic suggests that neuropathic pain, characterized by shooting or burning sensations, affects a significant proportion of the global population, with approximately 7-10% of individuals worldwide experiencing this type of pain. Neuropathic pain can result from various causes such as nerve damage, diabetes, or infections. The statistic highlights the widespread impact of neuropathic pain on individuals’ quality of life and calls attention to the need for better management and treatment strategies to address this commonly occurring type of chronic pain on a global scale.
At least 116 million adults in the United States are believed to suffer from chronic pain
The statistic ‘At least 116 million adults in the United States are believed to suffer from chronic pain’ denotes the estimated number of individuals aged 20 years and above who experience persistent or recurring pain for an extended period, typically lasting at least three months. Chronic pain can stem from various conditions such as arthritis, neuropathy, or back pain, and significantly impacts individuals’ quality of life, daily functioning, and mental well-being. This statistic highlights the substantial prevalence and burden of chronic pain in the U.S. population, emphasizing the need for effective pain management strategies, healthcare resources, and public awareness campaigns to address this widespread issue.
References
0. – https://www.www.futuremarketinsights.com
1. – https://www.www.alliedmarketresearch.com
2. – https://www.www.ncbi.nlm.nih.gov
3. – https://www.www.grandviewresearch.com
4. – https://www.www.fortunebusinessinsights.com
5. – https://www.www.marketresearchfuture.com
